PharmiWeb1d
Asthma & COPD Drugs Market Share & Forecast 2034
Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...
Taiwan News1d
Intelligent Asthma Monitoring Devices Market to Surpass USD 282.48 Million, Projected 25.1%+ CAGR Through 2030
Global Intelligent Asthma Monitoring Devices Market is valued at approximately USD 282.48 million in 2022 and is anticipated to grow with a healthy growth rate of more than 25.1% over the forecast ...
Daily2d
GSK Nucala application for COPD accepted for review in China
GSK plc has announced that the China National Medical Products Administration has accepted for review the new drug ...
GSK plc (GSK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...
Certain glucose-lowering meds associated with lower risk for COPD exacerbations
For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...
Pharmabiz4d
China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease
China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease: London, UK Friday, February 21, 2025, 09:00 Hrs [IST] GSK plc announ ...